Time-resolved phosphoproteomics reveals that platelet inhibition by prostacyclin analogs is a complex, multipronged process involving numerous previously unanticipated proteins and pathways.
No takes yet. Share an insight, caveat, or question.
Should not change clinical practice; leaves open whether novel pathways translate to human platelet inhibition.
Beck et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: